TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
190 hedge funds and large institutions have $3.58B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 101 increasing their positions, 39 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less call options, than puts
Call options by funds: $1.5M | Put options by funds: $2.89M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
190
Holding in Top 10
2
Calls
$1.5M
Puts
$2.89M
Top Buyers
| 1 | +$105M | |
| 2 | +$52.9M | |
| 3 | +$38.6M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$29.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.1M |
Top Sellers
| 1 | -$259M | |
| 2 | -$49.7M | |
| 3 | -$42.6M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$35.6M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.4M |